Neurolief

Private

#Migraine #Depression #Neuromodulation #Digital Therapeutics

Brain neuromodulation and digital therapeutics for migraine and depression. Products include Relivion (FDA-approved for migraine) and ProlivRx. Expanded VA contract for depression treatment.

Company Info

Sector:Medical Devices / Neuromodulation

Headquarters:Netanya, Israel

Founded:2015

Website:www.relivion.com/

Upcoming Milestones & Key Dates

2026 H2

Commercial

VA contract expansion for depression treatment

Clinical Development Pipeline

Relivion

Target: Occipital and trigeminal neuromodulation

Migraine

Preclinical

Phase 1

Phase 2

Phase 3

Approved

ProlivRx

Target: Brain neuromodulation

Depression

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Leadership Team

Scott Drees

Chief Executive Officer

Shmuel Shany

Founder

Careers & Job Openings

See all open roles

Apply Now →